Skip to main content
Clinical Trials/NCT03895723
NCT03895723
Unknown
Not Applicable

Minimally Invasive(Laparoscopic and Robotic) Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

Xu jianmin1 site in 1 country220 target enrollmentMarch 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Liver Metastasis
Sponsor
Xu jianmin
Enrollment
220
Locations
1
Primary Endpoint
disease-free survival (DFS)
Last Updated
7 years ago

Overview

Brief Summary

To examine survival of patients who underwent minimally invasive versus open liver resection for colorectal cancer with liver metastases.

Detailed Description

the minimally invasive procedure contain laparoscopic or robotic surgery

Registry
clinicaltrials.gov
Start Date
March 1, 2019
End Date
April 1, 2024
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Xu jianmin
Responsible Party
Sponsor Investigator
Principal Investigator

Xu jianmin

Director of colorectal cancer center

Fudan University

Eligibility Criteria

Inclusion Criteria

  • patients were diagnosed with colorectal cancer liver metastases
  • without extra-hepatic liver metastases
  • age were within 18-75 yeas
  • the numbers of metastases more than 3
  • the maximal tumor size of liver metastases more than 10 cm

Exclusion Criteria

  • liver metastases were unresectable.

Outcomes

Primary Outcomes

disease-free survival (DFS)

Time Frame: 3 years disease-free survival

DFS was calculated from the date of liver resection to the date of death or recurrence or new tumors developing

Secondary Outcomes

  • Overall survival (OS)(5 years overall survival)
  • Sugical complications(1 months after sugery)

Study Sites (1)

Loading locations...

Similar Trials